期刊文献+

溃疡性结肠炎患者血浆白介素-13检测和临床价值 被引量:5

Clinical significance of blood plasma level of interleukin 13 in patients with ulcerative colitis
下载PDF
导出
摘要 目的 探讨溃疡性结肠炎 (UC)患者血浆白介素 - 13(IL - 13)临床价值。方法 采用ELISA法检测UC患者和正常健康人血浆IL - 13浓度。结果  31例UC患者 (16 .6 5± 3.38)pg/ml和 30例健康人 (2 5 .83± 3.5 9)pg/ml血浆IL - 13浓度比较 ,差异有显著性 (P <0 .0 5 )。活动期 (2 1例 )和静止期 (10例 )UC患者血浆IL - 13浓度分别为(12 .0 3± 3.72 )pg/ml和 (18.6 7± 4 .2 2 )pg/ml,两者比较差异有显著性 (P <0 .0 5 )。轻、中、重度活动期UC血浆IL -13浓度相互比较 ,差异有显著性 (P <0 .0 5 )。UC患者血浆IL - 13和血清C -反应蛋白浓度呈负相关 (r=- 0 .5 98,P <0 .0 1)。结论 IL - 13参与UC的炎症过程 ,检测血浆IL - 13可作为判断UC患者病变严重程度和复发的指标之一。 Objective To explore clinical significance of blood plasma level of interleukin 13(IL-13) in patients with ulcerative colitis(UC).Methods The blood plasma level of IL-13 was detected by enzyme-linked immunosorbent assay(ELISA) in patients with UC.Results\ The blood plasma level of IL-13 in patients with UC(31 cases) was clear lower than that in normal people(30 cases)[(16.65±3.38) pg/ml vs (25.83±3.59) pg/ml,P<0.05].There are significant statistical differences between active UC(21 cases) and quiescent UC(10cases)[(12.03±3.72) pg/ml vs (18.67±4.22) pg/ml,P<0.05]. Comparing mild , moderate and severe UC , the blood plasma level of IL-13 was clear difference (P<0.05). The blood plasma level of IL-13 was negative correlation with serum level of C-reaction protein (r=-0.598,P<0.01).Conclusion\ IL-13 is involved in the process of inflammation in UC patients , and may act as one of index in judging UC severity and UC relapse.
出处 《医师进修杂志》 北大核心 2004年第9期16-17,共2页 Journal of Postgraduates of Medicine
关键词 白介素-13 溃疡性结肠炎 酶联免疫吸附法(ELISA) interleukin 13(IL-13) ulcerative colitis enzyme-linked immunosorbent assay (ELISA)
  • 相关文献

参考文献7

  • 1HIBI T,OHARA M,KOBAYASHI K,et al.Enzyme linked immunosorbent assay(ELISA) and immunoprecipitation studies on ant-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowlel disease[J].Gut,1994,35(2):224-230.
  • 2VAINER B,NIELSEN O,HENDEL J,et al. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease[J]. Cytokine,2000,12(10):1 531-1 536.
  • 3MALEFT R W,FIGDOR C G,HUIJBENS R,et al. Effects of IL-13 on phenetype,cytokine production, and cytotoxic function of human monocytes[J].J Immunol,1993,151(6):6 370-6 378.
  • 4MARIETTA E V,CHEN Y,WEIS J H.Modulation of expression of the anti-inflammatory cytokines interleukin-13 andinterleukin-10 by interleukin-4[J]. Eur J Immunol,1996,26(1):49-56.
  • 5SARTOR R B.Cytokines in intestinal inflammation: pathophysiological and clinical considerations[J]. Gastroenterology,1994,106(3):533-539.
  • 6LUGERING N,KUCHARZIK T,KRAFT M,et al. Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells[J]. Dig Dis Sci,1999,44(3):649-655.
  • 7KOLIOS G,ROONEY N,MURPHY C T,et al.Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines[J].Gut,1998,43(1):56-63.

同被引文献44

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部